diabetic

Amal Allam wrote Thursday, November 09, 2023 11:42 AM

The artificial pancreas technology – which costs less than £5,000 per patient – uses a ‘hybrid closed loop system’ sensor to continuously monitor blood glucose.

The sensor transmits the readings wirelessly to a high-tech insulin pump that performs a mathematical calculation to determine how much insulin should be delivered at one time to the body to keep blood glucose levels within a healthy range. The body-worn insulin pump then automatically delivers the insulin into the bloodstream.

According to the British newspaper Daily Mail, this can be a particular challenge for children due to differences in insulin levels required and the inability to know how much young people are taking. They are more at risk of dangerously low blood sugar levels (hypoglycemia) and high blood sugar levels (hypoglycemia). High blood sugar), which may cause damage and even death.

All children and young people, women who are pregnant or planning to become pregnant, and patients who already have an insulin pump, will be the first to receive this device as part of a 5-year plan in Britain.

Professor Jonathan Binger, NHS Chief Medical Officer, said: “With around 10% of the entire NHS budget spent on diabetes, it is important that the NHS focuses on what matters most by ensuring the best value-for-money technology is available to patients.” “For healthcare professionals and patients, the use of hybrid closed-loop systems will be a game-changer for people with type 1 diabetes.

The newspaper said that by ensuring that blood glucose levels are within the recommended range, people are less likely to develop complications such as hypoglycemia, strokes and heart attacks. This technology will improve the health and well-being of patients, and save the NHS money on the long term.”

Colette Marshall, chief executive of Diabetes UK, said the new technology has the potential to change the lives of many people with type 1 diabetes, improving health and quality of life.

“We are excited to welcome these recommendations that expand access to technology for key groups including children and youth,” she said.

However, the funding needed to roll out this technology to people who need it is paramount, and we reiterate the campaign call we made last month for the government and the NHS to agree to this.

We will also work with the NHS to help ensure everyone who could benefit from this technology has access to it as soon as possible in the phased implementation agreed to achieve this.

Dr Partha Kar, National Specialist Adviser on Diabetes, said: “This is amazing news for people with type 1 diabetes,” adding, “This technology may sound like science fiction, but it will have a huge impact on people’s quality of life, not to mention outcomes, as it can For people with type 1 diabetes to get on with their lives without worrying about glucose levels or medication.

The Juvenile Diabetes Research Foundation (JDRF) described this treatment as “the biggest therapeutic breakthrough for type 1 diabetes since the discovery of insulin.”

The newspaper explained that 150,000 type 1 diabetics are scheduled to receive a device that has been hailed as “the biggest achievement since the discovery of insulin.” NHS regulators have approved the hybrid closed-loop system technology.

More than 150,000 adults and children with type 1 diabetes are now eligible for an ‘artificial pancreas’.

NHS regulators have approved the hybrid closed-loop system technology, which experts say is “the biggest breakthrough since insulin”.

The high-tech device continuously tracks blood sugar levels through a sensor attached to the body. The readings are fed directly to a body-worn insulin pump, which then calculates how much of the hormone to release. An artificial pancreas could soon be introduced to manage type 1 diabetes. For NHS patients, after a major trial produced “absolutely impressive” early results, the high-tech kit continuously monitors glucose levels via sensors under the patient’s skin and, when needed, automatically delivers insulin into the bloodstream – a function it The body usually has the pancreas

An artificial pancreas could soon be provided for management diabetes Type 1 for NHS patients, after a major trial yielded “absolutely impressive” early results, this high-tech kit continuously monitors glucose levels via sensors under a patient’s skin and, when needed, automatically delivers insulin into the bloodstream – This is the function that the pancreas normally performs in the body.

2023-11-09 09:42:00

#Artificial #pancreas #therapeutic #revolution #type #diabetes #insulin